<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Doxorubicin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:51 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Doxorubicin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Doxorubicin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Doxorubicin_files/filelist.xml">
<title>DOXORUBICIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:04:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:22:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1907</o:Words>
  <o:Characters>10875</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>90</o:Lines>
  <o:Paragraphs>25</o:Paragraphs>
  <o:CharactersWithSpaces>12757</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>DOXORUBICIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Doxorubicin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> L01D B01.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Nhóm
anthracyclin. Ch&#7919;a ung th&#432;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm
l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>L&#7885; 10 mg, 20 mg, 50 mg doxorubicin
hydroclorid d&#7841;ng b&#7897;t &#273;ông khô. Tá d&#432;&#7907;c: lactose và
methylparaben &#273;&#7875; làm cho ho&#7841;t ch&#7845;t d&#7877; tan.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.2pt'>L&#7885; 10 mg/5 ml, 20 mg/10 ml, 50 mg/25 ml, 75
mg/37,5 ml (trong dung d&#7883;ch natri clorid 0,9% và acid hydrocloric &#273;&#7875;
&#273;i&#7873;u ch&#7881;nh dung d&#7883;ch có pH 3).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin là m&#7897;t kháng sinh thu&#7897;c nhóm anthracyclin gây
&#273;&#7897;c t&#7871; bào &#273;&#432;&#7907;c phân l&#7853;p t&#7915; môi
tr&#432;&#7901;ng nuôi c&#7845;y <i>Streptomyces peucetius</i> var. caecius. Hi&#7879;n
nay &#273;&#432;&#7907;c t&#7893;ng h&#7907;p t&#7915; daunorubicin.
Doxorubicin kích &#7913;ng m&#7841;nh các mô và có th&#7875; gây ho&#7841;i t&#7917;
mô, ví d&#7909; trong tr&#432;&#7901;ng h&#7907;p tiêm ra ngoài m&#7841;ch máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ho&#7841;t tính sinh h&#7885;c c&#7911;a doxorubicin là do doxorubicin
g&#7855;n vào DNA làm &#7913;c ch&#7871; các enzym c&#7847;n thi&#7871;t &#273;&#7875;
sao chép và phiên mã DNA. Doxorubicin gây gián &#273;o&#7841;n m&#7841;nh chu k&#7923;
phát tri&#7875;n t&#7871; bào &#7903; giai &#273;o&#7841;n phân bào S và giai
&#273;o&#7841;n gián phân, nh&#432;ng thu&#7889;c c&#361;ng tác d&#7909;ng trên
các giai &#273;o&#7841;n khác c&#7911;a chu k&#7923; phát tri&#7875;n t&#7871;
bào. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin có th&#7875; dùng &#273;&#417;n &#273;&#7897;c ho&#7863;c
ph&#7889;i h&#7907;p v&#7899;i thu&#7889;c ch&#7889;ng ung th&#432; khác. S&#7921;
kháng thu&#7889;c chéo x&#7843;y ra khi kh&#7889;i u kháng c&#7843; doxorubicin
và daunorubicin.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Chuy&#7875;n hóa và phân b&#7889; doxorubicin v&#7851;n &#273;ang
&#273;&#432;&#7907;c làm sáng t&#7887;. Doxorubicin chuy&#7875;n hóa ch&#7911;
y&#7871;u &#7903; gan t&#7841;o thành doxorubicinol và các aglycon. C&#7847;n
l&#432;u ý là m&#7897;t vài ch&#7845;t chuy&#7875;n hóa này c&#361;ng là các ch&#7845;t
gây &#273;&#7897;c t&#7871; bào nh&#432;ng không &#273;&#7897;c h&#417;n
doxorubicin. N&#7891;ng &#273;&#7897; cao các ch&#7845;t chuy&#7875;n hóa xu&#7845;t
hi&#7879;n nhanh trong huy&#7871;t t&#432;&#417;ng và qua giai &#273;o&#7841;n
phân b&#7889; v&#7899;i th&#7901;i gian n&#7917;a &#273;&#7901;i ng&#7855;n.
Chuy&#7875;n hóa ch&#7853;m &#7903; ng&#432;&#7901;i b&#7883; gi&#7843;m ch&#7913;c
n&#259;ng gan.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sau khi tiêm t&#297;nh m&#7841;ch, doxorubicin th&#7843;i tr&#7915;
qua 3 giai &#273;o&#7841;n và n&#7917;a &#273;&#7901;i c&#7911;a thu&#7889;c &#7903;
giai &#273;o&#7841;n cu&#7889;i kho&#7843;ng 30 gi&#7901;. Th&#7875; tích phân
b&#7889; kho&#7843;ng 25 lít/kg. Trong huy&#7871;t t&#432;&#417;ng kho&#7843;ng
70% doxorubicin liên k&#7871;t v&#7899;i protein. Trong vòng 5 ngày dùng thu&#7889;c,
kho&#7843;ng 5% li&#7873;u &#273;ào th&#7843;i qua th&#7853;n; trong vòng 7
ngày, kho&#7843;ng 40 - 50% th&#7843;i tr&#7915; qua m&#7853;t. N&#7871;u ch&#7913;c
n&#259;ng gan gi&#7843;m, th&#7843;i tr&#7915; ch&#7853;m h&#417;n, do v&#7853;y
c&#7847;n gi&#7843;m li&#7873;u dùng. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin qua hàng rào máu - não r&#7845;t ít, nh&#432;ng thu&#7889;c
qua &#273;&#432;&#7907;c hàng rào nhau - thai.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin không dùng &#273;&#432;&#7901;ng u&#7889;ng vì sinh kh&#7843;
d&#7909;ng r&#7845;t th&#7845;p (d&#432;&#7899;i 5%).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7881; &#273;&#7883;nh chính<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ung th&#432; vú, u x&#432;&#417;ng ác tính (sarcom x&#432;&#417;ng) và
u x&#432;&#417;ng Ewing, u mô m&#7873;m, u khí ph&#7871; qu&#7843;n, u lympho
ác tính c&#7843; 2 d&#7841;ng: Hodgkin và không Hodgkin, ung th&#432; bi&#7875;u
mô tuy&#7871;n giáp (carcinom tuy&#7871;n giáp).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ung th&#432; &#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u và sinh d&#7909;c:
Ung th&#432; t&#7917; cung, ung th&#432; bàng quang, ung th&#432; tinh hoàn. Kh&#7889;i
u &#273;&#7863;c c&#7911;a tr&#7867; em: Sarcom c&#417; vân (Rhabdomyosarcom),
u nguyên bào th&#7847;n kinh, u Wilm, b&#7879;nh leucemi c&#7845;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7881; &#273;&#7883;nh t&#432;&#417;ng &#273;&#7889;i<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ung th&#432; tuy&#7871;n ti&#7873;n li&#7879;t, ung th&#432; c&#7893;
t&#7917; cung, ung th&#432; âm &#273;&#7841;o, ung th&#432; &#273;&#7847;u c&#7893;,
ung th&#432; d&#7841; dày. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có tác d&#7909;ng t&#7889;t trên m&#7897;t s&#7889; ung th&#432; hi&#7871;m
g&#7863;p nh&#432;: Ða u t&#7911;y x&#432;&#417;ng, u màng ho&#7841;t d&#7883;ch,
u quái và u nguyên bào võng m&#7841;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có bi&#7875;u hi&#7879;n suy gi&#7843;m ch&#7913;c n&#259;ng t&#7911;y
x&#432;&#417;ng rõ.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Loét mi&#7879;ng ho&#7863;c có c&#7843;m giác nóng rát &#7903; mi&#7879;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Suy tim.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh &#273;ã &#273;i&#7873;u tr&#7883; b&#7857;ng
doxorubicin ho&#7863;c daunorubicin v&#7899;i &#273;&#7911; li&#7873;u tích l&#361;y.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Quá m&#7851;n c&#7843;m v&#7899;i doxorubicin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh b&#7883; b&#7879;nh tim. Suy gi&#7843;m ch&#7913;c
n&#259;ng t&#7911;y x&#432;&#417;ng (ch&#7913;c n&#259;ng t&#7841;o máu).
Ng&#432;&#7901;i b&#7879;nh &#273;ã &#273;i&#7873;u tr&#7883; b&#7857;ng
anthracyclin ho&#7863;c tia X li&#7879;u pháp &#7903; vùng trung th&#7845;t. Ð&#7897;c
tính &#273;&#7889;i v&#7899;i tim vì anthracyclin có tính ch&#7845;t tích l&#361;y
do t&#259;ng li&#7873;u và th&#7901;i gian &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin gây khuy&#7871;t t&#7853;t thai nhi và th&#432;&#7901;ng n&#7863;ng,
vì v&#7853;y vi&#7879;c ch&#7881; &#273;&#7883;nh doxorubicin ph&#7843;i h&#7871;t
s&#7913;c h&#7841;n ch&#7871; sau khi &#273;ã cân nh&#7855;c gi&#7919;a l&#7907;i
ích c&#7911;a m&#7865; và tác h&#7841;i &#273;&#7889;i v&#7899;i tr&#7867;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin bài ti&#7871;t vào s&#7919;a và gây h&#7841;i cho tr&#7867;.
Ng&#432;&#7901;i &#273;ang cho con bú c&#7847;n &#273;i&#7873;u tr&#7883; b&#7857;ng
doxorubicin nên cai s&#7919;a cho con.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; b&#7857;ng doxorubicin th&#432;&#7901;ng có nhi&#7873;u
tác d&#7909;ng không mong mu&#7889;n, m&#7897;t s&#7889; ph&#7843;n &#7913;ng
nghiêm tr&#7885;ng c&#7847;n &#273;&#432;&#7907;c theo dõi ch&#7863;t ch&#7869;
và giúp &#273;&#7905; c&#7911;a th&#7847;y thu&#7889;c. Tác d&#7909;ng không
mong mu&#7889;n th&#432;&#7901;ng ph&#7909; thu&#7897;c vào &#273;&#432;&#7901;ng
dùng và li&#7873;u dùng, t&#7889;c &#273;&#7897; dùng, t&#7847;n s&#7889; dùng.
Suy gi&#7843;m ch&#7913;c n&#259;ng t&#7911;y x&#432;&#417;ng là ph&#7843;n &#7913;ng
có h&#7841;i r&#7845;t nh&#7841;y v&#7899;i gi&#7899;i h&#7841;n li&#7873;u
dùng, nh&#432;ng có th&#7875; h&#7891;i ph&#7909;c. Bu&#7891;n nôn, nôn và r&#7909;ng
tóc th&#432;&#7901;ng th&#7845;y &#7903; t&#7845;t c&#7843; các ng&#432;&#7901;i
b&#7879;nh. M&#7897;t v&#7845;n &#273;&#7873; c&#7847;n chú ý là s&#7921; tích
l&#361;y thu&#7889;c gây &#273;&#7897;c cho tim, t&#7893;ng li&#7873;u t&#7889;i
&#273;a không nên v&#432;&#7907;t gi&#7899;i h&#7841;n 550 mg/m<sup>2</sup> da.
<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Chán &#259;n, s&#7889;t, chóng m&#7863;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>H&#7879; t&#7841;o máu: Suy gi&#7843;m ch&#7913;c n&#259;ng t&#7911;y
x&#432;&#417;ng, gi&#7843;m b&#7841;ch c&#7847;u, gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tu&#7847;n hoàn: B&#7879;nh c&#417; tim (2%), thay &#273;&#7893;i
&#273;i&#7879;n tâm &#273;&#7891; (ECG) trong th&#7901;i gian ng&#7855;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Bu&#7891;n nôn, nôn, viêm niêm m&#7841;c, &#7881;a ch&#7843;y,
chán &#259;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: R&#7909;ng tóc, ban &#273;&#7887; d&#7885;c theo t&#297;nh m&#7841;ch
tiêm thu&#7889;c, s&#7851;m màu móng tay, bong móng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các lo&#7841;i khác: Ph&#7843;n &#7913;ng t&#7841;i ch&#7895; gây kích
&#7913;ng bàng quang, &#273;&#7863;c bi&#7879;t ngay sau khi b&#417;m thu&#7889;c
vào bàng quang.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100 <o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trên da: Phát ban, ban &#273;&#7887;, mày &#273;ay lan r&#7897;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ti&#7871;t ni&#7879;u - sinh d&#7909;c: T&#259;ng acid uric máu.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Dùng cùng v&#7899;i cytarabin &#273;ôi khi gây loét và ho&#7841;i
t&#7917; &#273;&#7841;i tràng, &#273;&#7863;c bi&#7879;t bi&#7875;u mô manh
tràng. C&#7847;n chú ý theo dõi.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hi&#7871;m g&#7863;p, ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Ph&#7843;n &#7913;ng ph&#7843;n v&#7879;, rét run, hoa m&#7855;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>M&#7855;t: Viêm k&#7871;t m&#7841;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: <span style='letter-spacing:-.1pt'>Suy t&#7911;y x&#432;&#417;ng,
m&#7841;nh nh&#7845;t x&#7843;y ra sau 8 - 15 ngày &#273;i&#7873;u tr&#7883;,
nh&#432;ng máu s&#7869; tr&#7903; l&#7841;i bình th&#432;&#7901;ng sau 21 ngày.
Nên gi&#7843;m li&#7873;u ho&#7863;c kéo dài th&#7901;i gian ng&#7855;t quãng
dùng thu&#7889;c khi s&#7889; l&#432;&#7907;ng h&#7891;ng c&#7847;u không bình
th&#432;&#7901;ng tr&#7903; l&#7841;i trong th&#7901;i gian mong mu&#7889;n.<o:p></o:p></span></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Tu&#7847;n hoàn: Ð&#7897;c tính &#273;&#7889;i v&#7899;i
tim là m&#7897;t tác d&#7909;ng không mong mu&#7889;n c&#7847;n ph&#7843;i
&#273;&#432;&#7907;c h&#7871;t s&#7913;c chú ý trong khi &#273;i&#7873;u tr&#7883;
lâu dài. M&#7913;c &#273;&#7897; &#273;&#7897;c tính &#273;&#7889;i v&#7899;i
tim liên quan t&#7899;i t&#7893;ng li&#7873;u gây tích l&#361;y.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hai lo&#7841;i &#273;&#7897;c tính &#273;&#7889;i v&#7899;i tim
&#273;&#432;&#7907;c mô t&#7843; nh&#432; sau:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Bi&#7871;n &#273;&#7893;i ECG c&#7845;p
nh&#432;ng có h&#7891;i ph&#7909;c, x&#7843;y ra ngay ho&#7863;c trong vòng vài
gi&#7901; sau khi dùng thu&#7889;c. Nh&#7919;ng thay &#273;&#7893;i này h&#7891;i
ph&#7909;c &#273;&#432;&#7907;c, nh&#432;ng ít có bi&#7875;u hi&#7879;n lâm
sàng rõ ràng, &#273;&#7863;c bi&#7879;t c&#7847;n ph&#7843;i chú ý nguy c&#417;
lo&#7841;n nh&#7883;p tim và s&#7861;n sàng &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7879;nh c&#417; tim ph&#7909; thu&#7897;c vào t&#7893;ng li&#7873;u
tích l&#361;y, có th&#7875; phát tri&#7875;n sau m&#7897;t th&#7901;i gian dài
&#273;i&#7873;u tr&#7883;, cho m&#7897;t h&#7853;u qu&#7843; r&#7845;t nghiêm
tr&#7885;ng. Ph&#7843;n &#7913;ng này th&#432;&#7901;ng có &#273;&#7863;c
&#273;i&#7875;m là gi&#7843;m sóng QRS và ti&#7871;n tri&#7875;n nhanh giãn
c&#417; tim, th&#432;&#7901;ng không &#273;i&#7873;u tr&#7883; &#273;&#432;&#7907;c
b&#7857;ng b&#7845;t k&#7923; thu&#7889;c co s&#7907;i c&#417; tim nào. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ð&#7875; tránh b&#7879;nh c&#417; tim gây suy
tim, ph&#7843;i chú ý không s&#7917; d&#7909;ng t&#7893;ng li&#7873;u gây tích
l&#361;y là trên 550 mg/m<sup>2</sup> da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Các y&#7871;u t&#7889; làm t&#259;ng nguy c&#417; b&#7879;nh c&#417;
tim là chi&#7871;u tia x&#7841; vào vùng trung th&#7845;t &#7903; ng&#432;&#7901;i
có m&#7855;c b&#7879;nh tim t&#7915; <span style='letter-spacing:-.1pt'>tr&#432;&#7899;c
và ng&#432;&#7901;i cao tu&#7893;i. Nguy c&#417; s&#7869; gi&#7843;m n&#7871;u
dùng thu&#7889;c theo ch&#7871; &#273;&#7897; hàng tu&#7847;n. Theo dõi ch&#7913;c
n&#259;ng tim, &#273;&#7863;c bi&#7879;t là phân s&#7889; t&#7889;ng máu th&#7845;t
trái b&#7857;ng siêu âm tim là r&#7845;t c&#7847;n thi&#7871;t. Tuy v&#7853;y
có nhi&#7873;u tr&#432;&#7901;ng h&#7907;p b&#7879;nh c&#417; tim phát tri&#7875;n,
th&#7853;m chí hàng n&#259;m sau khi ng&#7915;ng &#273;i&#7873;u tr&#7883;. Ðo
cung l&#432;&#7907;ng tim trong quá trình &#273;i&#7873;u tr&#7883; là c&#7847;n
thi&#7871;t nh&#432;ng không nên &#273;ánh giá quá m&#7913;c vì nh&#432; v&#7853;y
có s&#7921; &#273;ánh giá sai v&#7873; an toàn. Nguy c&#417; luôn luôn cao n&#7871;u
t&#7893;ng li&#7873;u v&#432;&#7907;t quá 550 mg/m<sup>2</sup> di&#7879;n tích
da.</span><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Tiêu hóa: Bu&#7891;n nôn, nôn th&#432;&#7901;ng x&#7843;y
ra 24 gi&#7901; &#273;&#7847;u sau khi dùng thu&#7889;c. Viêm niêm m&#7841;c
(viêm mi&#7879;ng, th&#7921;c qu&#7843;n) sau 5 - 10 ngày, th&#432;&#7901;ng n&#7863;ng
và hay g&#7863;p h&#417;n khi &#273;i&#7873;u tr&#7883; 3 ngày liên t&#7909;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Loét và ho&#7841;i t&#7917; bi&#7875;u mô &#273;&#7841;i tràng, &#273;&#7863;c
bi&#7879;t &#7903; manh tràng có th&#7875; gây ch&#7843;y máu và nhi&#7877;m
khu&#7849;n nghiêm tr&#7885;ng, &#273;ôi khi gây t&#7917; vong. V&#7845;n
&#273;&#7873; này &#273;ã g&#7863;p &#7903; nh&#7919;ng ng&#432;&#7901;i b&#7879;nh
&#273;i&#7873;u tr&#7883; b&#7879;nh b&#7841;ch c&#7847;u t&#7911;y bào c&#7845;p
khi k&#7871;t h&#7907;p doxorubicin và cytarabin trong 3 ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: R&#7909;ng tóc, ph&#7909; thu&#7897;c vào li&#7873;u s&#7917; d&#7909;ng
và có th&#7875; bình ph&#7909;c sau khi ng&#7915;ng &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cách dùng<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7875; pha thu&#7889;c, hòa 10 mg b&#7897;t thu&#7889;c vào 5 ml
n&#432;&#7899;c &#273;&#7875; tiêm ho&#7863;c dung d&#7883;ch natri clorid 0,9%
ho&#7863;c dung d&#7883;ch glucose 5% và n&#7891;ng &#273;&#7897; dung d&#7883;ch
thu &#273;&#432;&#7907;c là 2 mg/ml. Khi cho dung d&#7883;ch hòa tan, thu&#7889;c
s&#7869; tan nhanh trong 30 giây, ch&#7881; c&#7847;n l&#7855;c nh&#7865;,
không c&#7847;n d&#7889;c ng&#432;&#7907;c l&#7885;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêm t&#297;nh m&#7841;ch là &#273;&#432;&#7901;ng dùng ph&#7893; bi&#7871;n
nh&#7845;t. Thu&#7889;c &#273;ã pha cho qua 1 dây truy&#7873;n t&#297;nh m&#7841;ch
nh&#7887; gi&#7885;t trong 2 - 3 phút, nh&#432; v&#7853;y s&#7869; làm gi&#7843;m
t&#7889;i &#273;a nguy c&#417; huy&#7871;t kh&#7889;i ho&#7863;c thu&#7889;c
thoát ra ngoài t&#297;nh m&#7841;ch gây ho&#7841;i t&#7917;. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêm &#273;&#7897;ng m&#7841;ch &#273;ã &#273;&#432;&#7907;c dùng
nh&#432;ng k&#7929; thu&#7853;t này r&#7845;t nguy hi&#7875;m và không
&#273;&#432;&#7907;c khuy&#7871;n cáo. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#417;m nh&#7887; gi&#7885;t vào bàng quang ngày càng &#273;&#432;&#7907;c
dùng nhi&#7873;u &#273;&#7875; &#273;i&#7873;u tr&#7883; các u nhú bàng quang
và carcinom t&#7841;i ch&#7895;, nh&#432;ng không &#273;&#432;&#7907;c dùng
&#273;&#7875; &#273;i&#7873;u tr&#7883; các u &#273;ã xâm l&#7845;n vào thành
bàng quang. N&#7891;ng &#273;&#7897; doxorubicin trong bàng quang ph&#7843;i là
50 mg/50 ml (1 mg/ml). Ð&#7875; tránh thu&#7889;c b&#7883; pha loãng do n&#432;&#7899;c
ti&#7875;u, ng&#432;&#7901;i b&#7879;nh không &#273;&#432;&#7907;c u&#7889;ng b&#7845;t
c&#7913; d&#7883;ch nào 12 gi&#7901; tr&#432;&#7899;c khi b&#417;m r&#7887; gi&#7885;t
bàng quang. Dung d&#7883;ch ph&#7843;i &#273;&#432;&#7907;c gi&#7919; 1 gi&#7901;
trong bàng quang, trong th&#7901;i gian &#273;ó ph&#7843;i h&#432;&#7899;ng d&#7851;n
ng&#432;&#7901;i b&#7879;nh c&#7913; 15 phút l&#7841;i thay &#273;&#7893;i
t&#432; th&#7871; (n&#7857;m nghiêng bên ph&#7843;i, bên trái) và cu&#7889;i
cùng ph&#7843;i &#273;ái h&#7871;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u l&#432;&#7907;ng:<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Khi dùng doxorubicin ph&#7843;i có s&#7921; ch&#7881;
d&#7851;n và theo dõi c&#7911;a bác s&#297; chuyên khoa có kinh nghi&#7879;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ng&#432;&#7901;i l&#7899;n: Dùng m&#7897;t thu&#7889;c
duy nh&#7845;t (doxorubicin), li&#7873;u b&#7855;t &#273;&#7847;u 60 - 75 mg/m<sup>2</sup>
di&#7879;n tích da (1,2 - 2,4 mg/kg) tiêm t&#297;nh m&#7841;ch, cách nhau 21
ngày/l&#7847;n. Dùng li&#7873;u th&#7845;p h&#417;n &#273;&#7889;i v&#7899;i
ng&#432;&#7901;i b&#7879;nh suy t&#7911;y. N&#7871;u k&#7871;t h&#7907;p
doxorubicin v&#7899;i 1 thu&#7889;c hóa tr&#7883; li&#7879;u khác, gi&#7843;m
li&#7873;u t&#7899;i 30 - 40 mg/m<sup>2</sup> di&#7879;n tích da tiêm t&#297;nh
m&#7841;ch cách nhau 21 ngày. M&#7897;t cách &#273;i&#7873;u tr&#7883; khác,
dùng m&#7897;t thu&#7889;c duy nh&#7845;t (doxorubicin) tiêm t&#297;nh m&#7841;ch
m&#7895;i tu&#7847;n 15 - 20 mg/m<sup>2</sup> </span><span style='font-size:
9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>ho&#7863;c
20 - 25 mg/m<sup>2</sup> <span style='letter-spacing:-.1pt'>di&#7879;n</span>
tích da (0,4 - 0,8 mg/kg) tiêm t&#297;nh m&#7841;ch trong 3 ngày li&#7873;n,
cách nhau 4 tu&#7847;n. Ð&#7875; tránh b&#7879;nh c&#417; tim, t&#7893;ng li&#7873;u
&#273;i&#7873;u tr&#7883; không &#273;&#432;&#7907;c v&#432;&#7907;t quá 550
mg/m<sup>2</sup> di&#7879;n tích da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tr&#7867; em: Li&#7873;u nh&#432; ng&#432;&#7901;i l&#7899;n có th&#7875;
phù h&#7907;p, nh&#432;ng nên gi&#7843;m li&#7873;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i cao tu&#7893;i: T&#7893;ng li&#7873;u không
&#273;&#432;&#7907;c v&#432;&#7907;t quá 450 mg/m<sup>2</sup> di&#7879;n tích
da &#273;&#7889;i v&#7899;i ng&#432;&#7901;i b&#7879;nh trên 70 tu&#7893;i. Li&#7873;u
ng&#432;&#7901;i l&#7899;n có th&#7875; phù h&#7907;p, nh&#432;ng nên gi&#7843;m
li&#7873;u n&#7871;u c&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7883; gi&#7843;m ch&#7913;c n&#259;ng gan, li&#7873;u
gi&#7843;m nh&#432; sau:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Bilirubin huy&#7871;t thanh là 24 - 50 micromol/lít (1,2 - 3,0 mg/100
ml): Li&#7873;u khuyên dùng là 50% li&#7873;u bình th&#432;&#7901;ng. N&#7871;u
trên 50 micromol/lít (trên 3,0 mg/100 ml): Nên dùng 25% li&#7873;u bình
th&#432;&#7901;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Giám sát ng&#432;&#7901;i b&#7879;nh trong khi &#273;i&#7873;u tr&#7883;<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883; b&#7857;ng
doxorubicin &#273;òi h&#7887;i ph&#7843;i theo dõi sát ng&#432;&#7901;i b&#7879;nh
và làm nhi&#7873;u xét nghi&#7879;m, nên ng&#432;&#7901;i b&#7879;nh c&#7847;n
&#273;&#432;&#7907;c nh&#7853;p vi&#7879;n trong giai &#273;o&#7841;n &#273;&#7847;u
&#273;i&#7873;u tr&#7883;. Ð&#7871;m h&#7891;ng c&#7847;u, b&#7841;ch c&#7847;u,
ch&#7913;c n&#259;ng gan, tim (&#273;&#7863;c bi&#7879;t phân s&#7889; <span
style='letter-spacing:-.2pt'>t&#7889;ng máu th&#7845;t trái b&#7857;ng siêu âm
tim) c&#7847;n &#273;&#432;&#7907;c th&#7921;c hi&#7879;n tr&#432;&#7899;c m&#7895;i
l&#7847;n &#273;i&#7873;u tr&#7883; b&#7857;ng doxorubicin.</span><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Trong khi truy&#7873;n, n&#7871;u ng&#432;&#7901;i b&#7879;nh kêu bu&#7889;t
ho&#7863;c rát b&#7887;ng &#7903; ch&#7895; tiêm, có ngh&#297;a là thu&#7889;c
&#273;ã thoát ra ngoài thành m&#7841;ch m&#7863;c dù hút máu v&#7851;n ra t&#7889;t,
ph&#7843;i ng&#7915;ng truy&#7873;n ngay và tìm m&#7897;t t&#297;nh m&#7841;ch
khác. C&#7847;n ch&#432;&#7901;m l&#7841;nh vùng tiêm và có th&#7875; tiêm t&#7841;i
ch&#7895; dexamethason ho&#7863;c hydrocortison &#273;&#7875; gi&#7843;m t&#7889;i
thi&#7875;u ho&#7841;i t&#7917;, c&#361;ng có th&#7875; bôi kem hydrocortison
1% vào ch&#7895; tiêm.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Chú ý: Khi &#273;i&#7873;u tr&#7883;, n&#432;&#7899;c ti&#7875;u s&#7869;
có màu &#273;&#7887;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Doxorubicin làm t&#259;ng &#273;&#7897;c tính c&#7911;a
mercaptopurin và azathioprin &#273;&#7889;i v&#7899;i gan.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin dùng cùng v&#7899;i propranolol s&#7869; làm t&#259;ng
&#273;&#7897;c tính &#273;&#7889;i v&#7899;i tim.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin dùng &#273;&#7891;ng th&#7901;i v&#7899;i actinomycin - D
và plicamycin có tr&#432;&#7901;ng h&#7907;p t&#7917; vong do b&#7879;nh
c&#417; tim.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng c&#7911;a doxorubicin có th&#7875; gi&#7843;m khi s&#7917;
d&#7909;ng &#273;&#7891;ng th&#7901;i v&#7899;i barbiturat.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>S&#7921; h&#7845;p th&#7909; c&#7911;a ciprofloxacin có th&#7875; gi&#7843;m
m&#7897;t n&#7917;a khi s&#7917; d&#7909;ng &#273;&#7891;ng th&#7901;i v&#7899;i
doxorubicin<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi s&#7917; d&#7909;ng &#273;&#7891;ng th&#7901;i doxorubicin cùng v&#7899;i
các thu&#7889;c gây &#273;&#7897;c t&#7871; bào khác nh&#432; warfarin có th&#7875;
làm t&#259;ng tác d&#7909;ng c&#7911;a thu&#7889;c này và gây ch&#7849;y máu
trong m&#7897;t s&#7889; tr&#432;&#7901;ng h&#7907;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Verapamil làm t&#259;ng tác d&#7909;ng c&#7911;a doxorubicin c&#7843;
trong môi tr&#432;&#7901;ng nuôi c&#7845;y mô và trên ng&#432;&#7901;i b&#7879;nh.
Thu&#7889;c làm t&#259;ng n&#7891;ng &#273;&#7897; c&#7911;a doxorubicin trong
máu.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dung d&#7883;ch tiêm doxorubicin và doxorubicin hydroclorid &#273;&#7875;
pha tiêm, nên b&#7843;o qu&#7843;n &#7903; nhi&#7879;t &#273;&#7897; 2 - 8<sup>o</sup>C,
tránh ánh sáng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin hòa tan nhanh. Dung d&#7883;ch &#273;ã pha &#7893;n &#273;&#7883;nh
trong kho&#7843;ng 12 gi&#7901; trong t&#7911; l&#7841;nh, t&#7889;t h&#417;n n&#7871;u
&#7903; nhi&#7879;t &#273;&#7897; 2 - 8<sup>o</sup>C, tránh ánh sáng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7881; s&#7917; d&#7909;ng nh&#7919;ng dung d&#7883;ch còn trong.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi pha ch&#7871; dung d&#7883;ch ph&#7843;i vô trùng và nên gi&#7919;
&#7903; nhi&#7879;t &#273;&#7897; cao nh&#7845;t là 8<sup>o</sup>C, tránh ánh
sáng. Ð&#7875; &#273;&#7843;m b&#7843;o vô khu&#7849;n, ch&#7881; &#273;&#432;&#7907;c
phép b&#7843;o qu&#7843;n dung d&#7883;ch sau khi pha ch&#7871; trong vòng 12
gi&#7901; tr&#432;&#7899;c khi s&#7917; d&#7909;ng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin không &#273;&#432;&#7907;c tr&#7897;n v&#7899;i b&#7845;t
c&#7913; thu&#7889;c nào sau &#273;ây (và c&#361;ng không &#273;&#432;&#7907;c
truy&#7873;n nh&#7887; gi&#7885;t trong cùng dây truy&#7873;n): Heparin,
fluorouracil, aminophylin, cephalothin, methotrexat, dexamethason, diazepam,
hydrocortison, furosemid.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin b&#7873;n v&#7919;ng trong dung d&#7883;ch truy&#7873;n ph&#7889;i
h&#7907;p v&#7899;i vincristin. M&#7897;t dung d&#7883;ch ph&#7889;i h&#7907;p
ph&#7893; bi&#7871;n trong dung d&#7883;ch natri clorid 0,9% ch&#7913;a
doxorubicin 1,4 mg/lít và vincristin 0,33 mg/lít.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin c&#361;ng có th&#7875; k&#7871;t h&#7907;p v&#7899;i
cyclophosphamid, dacarbazin, bleomycin, vinblastin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tri&#7879;u ch&#7913;ng lâm sàng: <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tri&#7879;u ch&#7913;ng quá li&#7873;u gi&#7889;ng nh&#432; tác d&#7909;ng
d&#432;&#7907;c lý c&#7911;a doxorubicin. Li&#7873;u dùng duy nh&#7845;t 250 và
500 mg &#273;ã gây t&#7917; vong. S&#7921; quá li&#7873;u có th&#7875; gây thoái
hóa c&#7845;p c&#417; tim trong vòng 24 gi&#7901; và gây suy t&#7911;y n&#7863;ng,
&#7843;nh h&#432;&#7903;ng này m&#7841;nh nh&#7845;t sau 10 - 15 ngày s&#7917;
d&#7909;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Suy tim có th&#7875; x&#7843;y ra ch&#7853;m, (6 tháng sau khi dùng
thu&#7889;c quá li&#7873;u). Ng&#432;&#7901;i b&#7879;nh c&#7847;n &#273;&#432;&#7907;c
theo dõi c&#7849;n th&#7853;n n&#7871;u có tri&#7879;u ch&#7913;ng xu&#7845;t
hi&#7879;n ph&#7843;i &#273;&#432;&#7907;c &#273;i&#7873;u tr&#7883; ngay.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;font-weight:normal'>X&#7917; trí:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; h&#7895; tr&#7907; tri&#7879;u ch&#7913;ng, c&#7847;n
&#273;&#7863;c bi&#7879;t chú ý &#273;i&#7873;u tr&#7883; và &#273;&#7873;
phòng nh&#7919;ng bi&#7871;n ch&#7913;ng n&#7863;ng có th&#7875; x&#7843;y ra
nh&#432; ch&#7843;y máu, nhi&#7877;m khu&#7849;n n&#7863;ng, suy gi&#7843;m t&#7911;y
x&#432;&#417;ng kéo dài.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Truy&#7873;n máu và ch&#259;m sóc ng&#432;&#7901;i b&#7879;nh c&#7849;n
th&#7853;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Doxorubicin có trong danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u
Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Doxorubicin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:51 GMT -->
</html>
